Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.325 CAD | -2.99% | -4.41% | -16.67% |
04-25 | Microbix to Present New Lab Accreditation Program at European Congress on Clinical Microbiology | MT |
03-27 | Transcript : Microbix Biosystems Inc. - Shareholder/Analyst Call |
Sales 2024 * | 18.59M 25.41M | Sales 2025 * | 21.32M 29.14M | Capitalization | 32.62M 44.59M |
---|---|---|---|---|---|
Net income 2024 * | - | Net income 2025 * | - | EV / Sales 2024 * | 1.75 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 1.53 x |
P/E ratio 2024 * |
16.3
x | P/E ratio 2025 * |
16.3
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 85.65% |
Latest transcript on Microbix Biosystems Inc.
1 day | -2.99% | ||
1 week | -4.41% | ||
Current month | -10.96% | ||
1 month | -15.58% | ||
3 months | -18.75% | ||
6 months | +12.07% | ||
Current year | -16.67% |
Managers | Title | Age | Since |
---|---|---|---|
Cameron Groome
CEO | Chief Executive Officer | - | 12-03-07 |
James Currie
DFI | Director of Finance/CFO | - | 16-10-31 |
Mark Luscher
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Mark Cochran
BRD | Director/Board Member | - | 90-09-30 |
Peter Blecher
BRD | Director/Board Member | - | 05-12-05 |
Cameron Groome
CEO | Chief Executive Officer | - | 12-03-07 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 0.325 | -2.99% | 166,766 |
24-04-25 | 0.335 | 0.00% | 2,500 |
24-04-24 | 0.335 | 0.00% | 21,500 |
24-04-23 | 0.335 | -1.47% | 44,286 |
24-04-22 | 0.34 | 0.00% | 41,786 |
Delayed Quote Toronto S.E., April 26, 2024 at 03:59 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-16.67% | 32.62M | |
+1.51% | 42.75B | |
+49.22% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- MBX Stock